Title : Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy.

Pub. Date : 2015 Jan 15

PMID : 25398452






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy. Paclitaxel cytochrome P450 family 3 subfamily A member 4 Homo sapiens
2 Relative to CYP3A4 wild-type patients, those carrying CYP3A4 defective variants had more severe neuropathy (2- and 1.3-fold higher risk of neuropathy for loss-of-function and missense variants, respectively, P = 0.045) and higher probability of neuropathy-induced paclitaxel treatment modifications (7- and 3-fold higher risk for loss-of-function and missense variants, respectively, P = 5.9 x 10(-5)). Paclitaxel cytochrome P450 family 3 subfamily A member 4 Homo sapiens
3 CYP3A4 defective variants may provide a basis for paclitaxel treatment individualization. Paclitaxel cytochrome P450 family 3 subfamily A member 4 Homo sapiens